field of Activities
1.
Gene Discovery For Seeds
2.
RNAi Based Products
3.
Cannabis Gene-Based Innovation (In Targene)
Gene discovery for seeds
What we do?
With our patented DIP™ (Direct-In-Plant) technology, we discover & develop genes with positive effects on plants, more effectively than ever before. We focus on positive effects such as yield improvement, drought resistance, herbicide & insects tolerance.
Use case
Our genes are being implemented inside largest global crops (such as Soy, Corn, Canola etc.) leveraging Genetically modification and Gene editing processes. Patents- We issued patents on our DIP technology, as well as all genes discovered using it.
strategic partners
We partner with global seeds companies. To date, 4 large seeds companies implementing our genes. Among them are KWSand Rallis, a Tata enterprise company
and more
RNAi based products
What we do?
We are global leaders in the development of RNAi based external applications for crop protection and yield enhancement. The externally applied RNAi molecules affect specific genes for specific time period, resulting the required positive effects.
Patents- we issued patents on each RNAi based application we develop
Use case
The 1st two projects that are in an advanced development stages are RNAi application for yield improvement in Canola, as well as RNAi application for controlling the Red Palm Weevil, a global insect attacking palm trees
strategic partners
We develop our products with 3 strategic partners, that are responsible on the production and commercialization of our products. Among them are ICL and Gadot Agro
and more
Cannabis Gene-Based Innovation (In Targene)
What we do?
Together with Seach Medical Group, we established Targene-
that is focused on revolutionizing the cannabis industry with gene-based innovations.
Use case
We are focusing on 3 activities: (1) production of active molecules (such as CBD/THC) in a bioreactor in large scale, and (2) gene-editing in Cannabis to develop improved strains.
